Perceptive Advisors LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
86
Total Value
2694161578
Accession Number
0001012975-25-000242
Form Type
13F-HR
Manager Name
Perceptive Advisors LLC
Data Enrichment
87% identified
75 identified11 unidentified

Holdings

86 positions
Manager:
Search and click to pin securities to the top
Adaptive Biotechnologies Corp
Shares:
930972
Value:
$6.9B
OCULAR THERAPEUTIX, INC
Shares:
915775(-15.1%)
Value:
$6.7B(-27.1%)
DELCATH SYSTEMS, INC.
Shares:
462422(+824.8%)
Value:
$5.9B(+877.8%)
RAPT Therapeutics, Inc.
Shares:
4418947(-24.8%)
Value:
$5.4B(-42.0%)
G52441105
Shares:
200000
Value:
$5.0B
G4444H101
Shares:
398000(-20.4%)
Value:
$4.5B(-14.3%)
OnKure Therapeutics, Inc.
Shares:
1004439(+0.0%)
Value:
$4.3B(-50.0%)
67577R102
Shares:
4325000
Value:
$4.2B
Avalo Therapeutics, Inc.
Shares:
520000
Value:
$4.2B
Nurix Therapeutics, Inc.
Shares:
297553(-10.0%)
Value:
$3.5B(-43.2%)
Mereo BioPharma Group plc
Shares:
876961(-19.2%)
Value:
$2.0B(-48.1%)
Lyra Therapeutics, Inc.
Shares:
12757562(+0.0%)
Value:
$1.6B(-38.8%)
KALA BIO, Inc.
Shares:
277610
Value:
$1.6B
Athira Pharma, Inc.
Shares:
5402964(+0.0%)
Value:
$1.5B(-51.4%)
BIODESIX INC
Shares:
2173880(+0.0%)
Value:
$1.4B(-59.1%)
scPharmaceuticals Inc.
Shares:
500000(+0.0%)
Value:
$1.3B(-25.7%)
Traws Pharma, Inc.
Shares:
421781(+156.9%)
Value:
$970.1M(-33.5%)
ROCKET PHARMACEUTICALS, INC.
Shares:
140726(-62.8%)
Value:
$938.6M(-80.3%)
Cullinan Therapeutics, Inc.
Shares:
80100
Value:
$606.4M
Lexeo Therapeutics, Inc.
Shares:
139835(+0.0%)
Value:
$485.2M(-47.3%)